Patent Damages – Pharmaceuticals
Insight Economics provided reasonable royalty damages analysis and expert testimony in high‑stakes pharmaceutical patent litigation between the United States government and Gilead Sciences involving…
Trade Secrets Damages and Irreparable Harm – Pharmaceuticals
Insight was retained to provide a rebuttal opinion on damages from alleged misappropriation of Lupin’s trade secrets relating to generic drug development. Insight was…
Commercial Success – ANDA Litigation
Insight Economics provided expert economic testimony for generic defendants in a high‑stakes ANDA pharmaceutical patent case involving Acorda Therapeutics’ patents on Ampyra, a drug…
Antitrust and Breach of Contract Damages – Consumer Products
Insight Economics was retained by a seller of cigarillos, which brought antitrust and breach of contract claims against its supplier. Insight Economics’ analysis was extensive and was relied upon at trial.
Patent Damages, Lost Profits, Reasonable Royalty – Industrial Equipment
Insight Economics was retained to evaluate damages related to alleged infringement of a patent pertaining to a vehicle spray washer with lighted spray arms.…
Price Discrimination, Competitive Harm, and Damages – Consumer Products
Insight Economics was engaged in a California antitrust matter involving L.A. International Corp. and Prestige Consumer Healthcare, Inc., the maker of Clear Eyes. The…
Preliminary Injunction – Biologics
Insight Economics evaluated claims regarding a motion to preliminarily enjoin the authorization of a private label version of a biologic drug. The dispute centered…
No case studies match those filters.
